Storgate’s Boston Scientific BSX Stock Holding History

Storgate’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$445K	Buy	10,434 +6,907	+196%	+$375K	0.09%	218
2026 Q1	$221K	Buy	3,527 +545	+18%	+$43.6K	0.17%	156
2025 Q4	$284K	Buy	+2,982	New	+$292K	0.23%	128

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Storgate's BSX Position: Q2 2026 in Review

Storgate increased its Boston Scientific (BSX) stake by 196% in Q2 2026, buying an estimated $375K and bringing the position to 10,434 shares worth $445K. The position accounts for 0.09% of the portfolio, ranked #218.

Storgate first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Storgate held 10,434 shares of Boston Scientific worth $445K as of Q2 2026.
Storgate bought 6,907 Boston Scientific shares in Q2 2026, an estimated $375K.
Boston Scientific made up 0.09% of Storgate's portfolio in Q2 2026, its #218 holding.
Storgate first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Storgate's 13F filing for Q2 2026, filed 12 Aug 2026.